3rd Quarter - Report

BROAD INSTITUTE INC. for BROAD INSTITUTE INC.

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Support for the NIH All of Us Program. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495).

LobbyistCovered position, as disclosed
NAMRATA SENGUPTA —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Office of Science & Technology Policy (OSTP); Defense, Dept of (DOD); Natl Institutes of Health (NIH); Office of Management & Budget (OMB)

Bills named: H.R. 9260 (119th), S. 4784 (119th), H.R. 8800 (119th), H.R. 9495 (119th)

Science/Technology SCI

- General education about biomedical research and support for scientific funding. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal policies related to Office of Management and Budget (OMB) Uniform Guidance and their implications for federally funded biomedical research and research institutions. - Federal science and technology policy, including Office of Science and Technology Policy (OSTP) priorities related to the future of federally supported research, scientific institutions, and national research capabilities. - Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

LobbyistCovered position, as disclosed
NAMRATA SENGUPTA —

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

- General education about biomedical research and support for scientific funding. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Education and awareness regarding genetic medicines for rare and ultra-rare diseases.

LobbyistCovered position, as disclosed
NAMRATA SENGUPTA —

Contacted: SENATE; Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP)

Defense DEF

- Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495). - Education and discussion regarding Broad Institute capabilities and technologies relevant to national biological intelligence, biosurveillance, and reconnaissance (ISR). - General education regarding Broad Institutes research capabilities and areas of potential relevance to Defense Advanced Research Projects Agency (DARPA) programs and priorities.

LobbyistCovered position, as disclosed
NAMRATA SENGUPTA —

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Defense Advanced Research Projects Agency (DARPA)

Bills named: H.R. 8800 (119th), H.R. 9495 (119th), S. 4784 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.